Daytrana Safety: 12 Month Data Is InBy
Daytrana, the skin patch for ADD/ADHD now has research demonstrating that it is safe over a 12 month period. The research was reported at the annual meeting of the American Academy of Child and Adolescent Psychiatry, in Boston in October 2007.
This is important research, to help to establish the safe longer term use of this medicine.
Daytrana is the first skin patch of the medicine methylphenidate. Methylphenidate is the same active ingredient as Ritalin, Concerta,
Metadate CD, Methylin and Biphentin. It can play a role in the treatment of ADHD, especially in children who have trouble swallowing tablets or pills.
Daytrana is one option used in the medication treatment of ADD/ADHD. Research has proven that the best treatment for ADD/ADHD is a comprehensive, multimodal approach.
To get free information about the medication treatment of ADHD, please visit: ADHD Medication Mastery to download a free report that I’ve written for you.